Everist Genomics

Everist Genomics Provides Technologies for Diagnosis, Prognosis, and Treatment Selection. Last year, the company launched its first product, OncoDefender-CRC, a prognostic test designed to predict the risk of disease recurrence in patients with early-stage colorectal cancer.